Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Vonovia currently controls 72.3% of the votes in Hembla

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD VIOLATE THE LAWS OF SUCH JURISDICTION.  DETAILED INFORMATION ABOUT THE OFFER, INCLUDING THE OFFER DOCUMENT, IS AVAILABLE AT https://en.vonovia-h.de.PRESS RELEASE · Following completion of the acquisition of Blackstone’s shares in Hembla and purchase of shares in the market, Vonovia currently owns approximately 72.3% of the voting rights (approximately 65.0% of the share capital) in Hembla · Statement from Hembla’s independent bid committee regarding the

Fotografiska Stockholm opens Alex Prager Welcome Home

Alex Prager  Welcome Home 22nd November 2019-8th March 2020 Fotografiska Stockholm Born and raised in Los Angeles, Alex Prager’s inherent connection to Hollywood and her love of cinema, is as obvious as it is fascinating. Describing the city’s Wild West quality of no rules as one of her greatest inspirations, Prager started with guerilla style photography and film and then moved into more elaborately staged tableaux’s inspired by her personal life and the state of society. In Welcome Home at Fotografiska Stockholm, Prager seeks out the darker side of human nature, or reality,

Calquence approved in CLL in the US

21 November 2019 18:10 GMT   Calquence approved in the USfor adult patients with chronic lymphocytic leukaemia  Two Phase III Calquence trials demonstrated superior progression-free survival across multiple settings while maintaining favourable tolerability  Calquence combined with obinutuzumab and as monotherapy reducedthe risk of disease progression or death by 90% and 80%,respectively in ELEVATE-TN   AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved Calquence (acalabrutinib) for adult patients with chronic lymphocytic

A Distant Land close to us all – Pentti Sammallahti at Fotografiska Stockholm

Pentti Sammallahti Distant Land 22 November 2019-8 March Fotografiska Stockholm “In the Eye of the Beholder” is a beautiful saying full of mystery. What is actually in the eye of the beholder, how much of yourself is in every observation you make? And are you aware of how much your interpretation is part of a creation? There is a need for mystery in the materialistic Western world. And the work of Pentti Sammallahti meets those needs in the most gentle, humoristic and thoughtful way. A poetic observer with a unique and inclusive eye to the world around him, recognized as a master

Nordic Nanovector ASA - Financial calendar

Oslo, Norway, 21 November 2019 FINANCIAL YEAR 2019 27.02.2020 - Quarterly Report - Q4   FINANCIAL YEAR 2020 17.04.2020 - Annual General Meeting 26.05.2020 - Quarterly Report - Q1 27.08.2020 - Half-yearly Report - Q2 19.11.2020 - Quarterly Report - Q3   The dates are subject to change. The time and location of the presentations will be announced in due time.   This information is published pursuant to the requirements set out in the Continuing obligations.   For further information, please contact:  IR enquiries Malene Brondberg, VP Investor

BATTLETECH: Heavy Metal Expansion Now Available on Steam for PC, Mac, and Linux

Award-Winning Turn-Based Tactical ‘Mech Combat Game from Paradox Interactive Introduces New ‘Mechs, Mini-Campaign and Weapon SystemsSTOCKHOLM - November 21, 2019 - Paradox Interactive and Harebrained Schemes today released Heavy Metal, the latest expansion to BATTLETECH, the turn-based tactical ‘Mech combat game for PC, Mac and Linux. Available for a suggested retail price of $19.99 / £15.49 / €19.99, and included as the final expansion in the BATTLETECH - Season Pass, Heavy Metal features eight new ‘Mechs each with unique equipment, a Flashpoint mini-campaign, and eight weapon systems.

Brighter invests in a digital healthcare provider and initiates partnership for digital health services

Brighter AB (publ) ("Brighter") has today entered into an agreement by which Brighter invests SEK 9 million in the healthcare provider Accumbo AB. The investment corresponds to approximately 13 percent of the shares and votes in Accumbo. The investment will be used for expansion and development of new services for both digital and physical healthcare. The partnership starts with Brighters diabetes service Actiste® and Accumbo's care service for high blood pressure. Since the launch of Blodtrycksdoktorn (“the Blood Pressure Doctor”) earlier this year, Accumbo has treated more than two

British innovation beneath some of the world’s biggest theme park rides

WHEN you’re on some of the best-known theme park rides in the world, you’ll be glad to know you’ve got the very best technology beneath your feet. British-made Marl LED panel indicator lamps have been the go-to equipment of choice for some of the most popular theme parks in North America for 20 years. Now the UK company is looking to other markets which would benefit from the high-spec, high quality, outstandingly reliable LED lamps. Marl’s 690 series lamps have been particularly popular in the theme park sector because of their ability to withstand high vibration. The lamps are

Bulletin from Annual General Meeting of Diamyd Medical AB

The Annual General Meeting of Diamyd Medical AB (publ) was held on November 21, 2019. The Company's income statement and balance sheet were adopted, and the Board members and the Chief Executive Officer were discharged from liability for the fiscal year 2018/2019. The Annual General Meeting approved the Board's proposal that no dividend be paid for the fiscal year 2018/2019. Erik Nerpin was re-elected as Chairman of the Board and Anders Essen-Möller, Maria-Teresa Essen-Möller, Torbjörn Bäckström and Mark A. Atkinson were re-elected to the Board. The Annual General Meeting approved

Press release from Annual General Meeting in Internationella Engelska Skolan i Sverige Holdings II AB (publ) on 21 November 2019

At the Annual General Meeting (AGM) in Internationella Engelska Skolan i Sverige Holdings II AB (publ) in Stockholm today the shareholders resolved upon the following: Approval of income statement and balance sheet for the financial year 2018/2019 and discharge from liability The AGM approved the income statement and balance sheet as well as the consolidated income statement and the consolidated balance sheet for the financial year 2018/2019, and the members of the board and the managing directors were discharged from liability for the financial year 2018/2019. Allocation of profit

Statement by the independent bid committee of Hembla in view of Vonovia’s cash offer

Hembla’s independent bid committee unanimously recommends the shareholders not to accept Vonovia’s cash offer. Background                                                                                                                         This statement is made by Hembla AB (publ)’s (“Hembla” or the “Company”) independent bid committee pursuant to section II.19 of the Nasdaq Stockholm takeover rules (the “Takeover Rules”). Vonovia SE[1], through its indirectly wholly-owned subsidiary HomeStar InvestCo AB[2] (“Vonovia”), has on 7 November 2019 announced a cash offer to the

Holiday Specials from California Inns

Holiday Specials from California Inns SACRAMENTO, CA [November 21, 2019]--Nestle into the warmth of the holidays with a stay at a California boutique inn or bed and breakfast. California inns welcome travelers with crackling fires, festive decor, and an array of holiday travel specials and packages. Guests who book any two-night stay at Olallieberry Inn  during Cambria Christmas Market will receive complementary tickets for two to the event. The market offers the opportunity to shop with artisan vendors, walk through over two million lights,

FISKARS CORPORATION: ACQUISITION OF OWN SHARES 21.11.2019

Fiskars Corporation  NOTIFICATION 21.11.2019 at 18:30 EET/EEST FISKARS CORPORATION: ACQUISITION OF OWN SHARES 21.11.2019 Date 21.11.2019Exchange transaction BuyShare class FSKRSAmount       1000Average price/share 11.7702 EUR  Highest price/share 11.8200 EUR Lowest price/share 11.7400 EUR Total price  11,770.20 EUR  The shares held by Fiskars Corporation on 21.11.2019: FSKRS 385,677  On behalf of Fiskars Corporation Skandinaviska Enskilda Banken AB (Publ) Antti Salakka   Mikko

OCEAN YIELD: FULLY UNDERWRITTEN PRIVATE PLACEMENT OF NEW SHARES

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Ocean Yield ASA (the “Company” or "Ocean Yield") has retained Arctic Securities AS, DNB Markets, part of DNB Bank ASA and Fearnley Securities AS as joint bookrunners (the “Joint Bookrunners”) and ING Bank N.V., SpareBank 1 Markets AS and Swedbank

ContextVision announces first digital pathology patent granted for its unique and objective data-generation method

STOCKHOLM – November 21, 2019 – ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, announce today that its proprietary Master Annotation method has received patent protection in the U.S. The U.S. Patent and Trademark Office (USPTO) has granted a patent to ContextVision for this invention, titled “method and system for detecting pathological anomalies in a digital pathology image and method for annotating a tissue slide”. ContextVision developed this method to automatically and more objectively outline specific structures in

Acquisition of four LR2 product tankers with long-term charter

Ocean Yield ASA ("Ocean Yield" or the "Company") is pleased to announce that the Company has agreed to acquire four modern LR2 product tankers with long-term charter to companies owned and guaranteed by Navig8 Topco Holdings Inc. (“Navig8 Group”) from a major Chinese leasing company. The net purchase price is around USD 132 million in total, or an average price of USD 33 million per vessel, depending on the closing date for each vessel, which is expected to be during the fourth quarter of 2019. The scrubber fitted vessels are built in 2018 and 2019 with about 9 year’s remaining bareboat

#19-1140 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details see attached file. For further information concerning this NGM notice please contact:Listing on +46 8 566 390 20 or at listings@ngm.se.  Nordic Growth Market NGM AB  About NGM Nordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

Election of company employee representatives for the Board of Directors of Vestas Wind Systems A/S

The employees of Vestas Wind Systems A/S have held the ordinary election for representation in the Board of Directors according to the current Danish law on employee representation. The following members were elected for the next four years:  Name Place of employmentSussie Dvinge Agerbo (re Vestas Wind Systems A/S Plant & Hybrid Solutions-elected) ManagementAssistent   Peter Lindholst (re Vestas Wind Systems A/S Concept Development-elected) Vice President    The elected employee

Nyfosa issues senior unsecured bonds of MSEK 750

Nyfosa AB (”Nyfosa”) has successfully placed MSEK 750 senior unsecured bonds within the current framework of BNSEK 1.5 (ISIN: SE0012569655) with final maturity in May 2022. Total outstanding volume after the issue amounts to BNSEK 1.5. The previously issued bonds are listed on Nasdaq Stockholm and Nyfosa will apply for the new issued bonds to be admitted to trading on Nasdaq Stockholm as well. The bonds were issued at a price of 101.6%, which implies an interest margin of 300 basis points. The bonds have a floating interest rate of STIBOR 3M + 375 basis points. The proceeds from the

OptiGroup acquires Walki Medical Oy in Finland

VeliMark Oy, OptiGroup's Finnish company within the Facility, Safety & Foodservice business area, today announces the acquisition of Walki Medical Oy. Walki Medical is one of Finland's largest distributors of medical supplies with a turnover of EUR 14 million in 2018. The purchase price has not been disclosed. VeliMark, with a turnover of 45 million euros, is a leading supplier of cleaning and facility management supplies in Finland. Through the acquisition, the Facility, Safety & Foodservice business area will broaden its customer offering to include medical supplies to Finnish

Holdings in Company

Faron Pharmaceuticals Oy Company announcement, Turku, 21 November 2019 at 16:00 (EET)  TR-1: Standard form for notification of major holdings   NOTIFICATION OFMAJOR HOLDINGS (tobe sent to therelevantissuer and to theFCA in MicrosoftWord format ifpossible)i 1a. Identity of the Faronissuer or the Pharmaceuticalsunderlying issuer of Ltdexisting sharesto which votingrights areattachedii:1b. Please indicateif the issuer isa non-UK issuer (please

Obducat receives order from German customer at a value of 6 million SEK

OBDUCAT AB (publ) subsidiary Obducat Europe GmbH, a leading supplier of system solutions for lithography processing, has received a repeat order from an existing customer in Germany, for the supply of a MC 204 fully automated resist processing system. The order value amounts to approx.6 million SEK. The fully automated MC 204 resist processing system will be used for production purposes and it will be equipped with a function that enables inline quality control. The ordered tool is the second tool of this type that the customer orders and the purpose is to increase production capacity.

CELLINK launches new bioinks to further strengthen the company’s bioink portfolio

Today, CELLINK launches the next part of a multiphase bioink expansion. This phase includes the release of two new bioink series, the expansion of three existing bioink series, the release of a new thickener series and two products for enhanced cell analysis. With this launch, the company offers a wider range of tools for researchers around the world and further strengthens its bioink portfolio.New bioink series: Chitosan: Chitosan is an abundant biocompatible material which has been used in research related to cartilage, skin and bone tissue engineering. Previously, chitosan’s use

There are no items matching the current filter
There are no more items matching the current filter
Back to top